Evidence-Based Complementary and Alternative Medicine / 2012 / Article / Tab 1

Research Article

Uncaria tomentosa—Adjuvant Treatment for Breast Cancer: Clinical Trial

Table 1

Clinical characteristic of patients. It represents age, body mass index (BMI), total cholesterol levels, estrogen receptor (ER), and progesterone receptors (PR), as well as the HER-2 status in different groups.

Clinical parametersControl Ca UtCa

Age interval32–7932–7140–75
Mean age
BMI
Cholesterol levels
Estrogen receptor status (ER)
 Positive
 Negative
Progesterone receptor status (PR)
 Positive
 Negative
HER-2 receptor status (HER2)*
 Positive
 Negative

The results for ER, HER2, and REP are represented as positive and negative numbers for the expression of receptors by number of women, while other parameters are expressed as mean ± standard deviation. UtCa group: patients treated with chemotherapy +300 mg Uncaria tomentosa daily ; Ca group: patients received chemotherapy ; control group .
*To HER-2 receiver only data were obtained from 18 patients.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.